Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2011 R21 RFA-CA-10-001 HAGEDORN, CURT H. UNIVERSITY OF UTAH SENTINEL POL II RNAS FOR MEASURING RNA INTEGRITY IN BIOSPECIMENS Complete
2015 R21 RFA-CA-14-003 MACCOSS, MICHAEL UNIVERSITY OF WASHINGTON SYSTEMATIC AND COMPREHENSIVE SAMPLING OF PEPTIDES IN MIXTURES BY TANDEM MASS SPECTROMETRY Complete
2018 R21 RFA-CA-17-010 ABBOTT, KAREN L UNIV OF ARKANSAS FOR MED SCIS Novel platform linking cancer-specific glycosylation with cell signaling outcomes Complete
1999 R21 PAR-98-067 GARNER, HAROLD R UNIVERSITY OF TEXAS SW MED CTR/DALLAS SOFTWARE AND INSTRUMENTATION TO IDENTIFY CANCER GENES Complete
2001 R33 PAR-99-100 HERLYN, DOROTHEE M WISTAR INSTITUTE MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2007 R21 RFA-CA-07-003 ROGERS, RICK HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) SAMPLE PREP METHODS TO ALLOW AUTOMATED 3D ANALYSIS OF MICROVESSEL MORPHOLOGY Complete
2010 R21 RFA-CA-09-004 POPESCU, GABRIEL UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN LABEL FREE IMAGING OF BLOOD SMEARS AND TISSUE BIOPSIES Complete
2013 R44 RFA-CA-08-011 DUFFY, DAVID C QUANTERIX CORPORATION SINGLE MOLECULE FIBER ARRAYS FOR THE DETECTION OF LOW ABUNDANCE PROTEINS Complete
2017 R21 RFA-CA-16-001 NAEGLE, KRISTEN M WASHINGTON UNIVERSITY A MOLECULAR TOOLKIT FOR THE PRODUCTION OF TYROSINE PHOSPHORYLATED PROTEINS Complete
2020 R33 RFA-CA-19-020 WEI, CHIA-LIN JACKSON LABORATORY Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer Complete
2000 R43 PAR-99-101 WOOD, KATHERINE A TREVIGEN, INC. HIGH THROUGHPUT DNA REPAIR CAPACITY ASSAY Complete
2002 R43 PAR-01-105 JOHNSON, PAUL H EPIGENX PHARMACEUTICALS TECHNOLOGY FOR GENOME-WIDE CANCER METHYLATION PROFILING Complete
2006 R33 RFA-CA-06-002 BRENT, ROGER VTT/MSI MOLECULAR SCIENCES INSTITUTE TADPOLE ASSAYS FOR THE MOLECULAR ASSESSMENT OF CANCER Complete
2009 R21 RFA-CA-08-006 BURBULIS, IAN E VTT/MSI MOLECULAR SCIENCES INSTITUTE PCR FOR CARBOHYDRATE CANCER BIOMARKERS Complete
2013 R21 RFA-CA-12-002 PAN, TINGRUI UNIVERSITY OF CALIFORNIA AT DAVIS DIGITAL ONE-DISC-ONE-COMPOUND ARRAY FOR HIGH-THROUGHPUT DISCOVERY OF CANCER-TARGE Complete
2016 R33 RFA-CA-15-003 GARRAWAY, LEVI A BROAD INSTITUTE, INC. CLINICAL IMPLEMENTATION OF SINGLE CELL TUMOR TRANSCRIPTOME ANALYSIS Complete
2019 R21 RFA-CA-18-004 ANDRES-MARTIN, LAURA NEW YORK STEM CELL FOUNDATION Establishing efficient technologies for ovarian cancer organoid derivation from fresh tumor resections Complete
2000 R21 PAR-99-102 BROCK, GRAHAM J UNIVERSITY OF GLASGOW IDENTIFICATION OF M5CPG ALTERATIONS IN BREAST CARCINOMAS Complete
2002 R33 PAR-99-100 CHEE, MARK S. ILLUMINA, INC. PROTEIN PROFILING ARRAYS Complete
2005 R33 RFA-CA-05-004 CHAURAND, PIERRE VANDERBILT UNIVERSITY PREPARATION OF CANCER TISSUES FOR MS IMAGING OF PROTEINS Complete
2008 R33 RFA-CA-07-036 BOGDANOV, ALEXEI A UNIV OF MASSACHUSETTS MED SCH WORCESTER TRANSCRIPTION FACTOR REPORTER TECHNOLOGY Complete
2011 R33 RFA-CA-10-004 TANG, KEQI BATTELLE PACIFIC NORTHWEST LABORATORIES VALIDATION AND ADVANCED DEVELOPMENT OF EMERGING TECHNOLOGIES Complete
2015 R33 RFA-CA-14-004 YEAKLEY, JOANNE MULLIGAN BIOSPYDER TECHNOLOGIES, INC. RASL-SEQ EXPRESSION PROFILING OF FFPE TISSUES Complete
2019 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development of the High Throughput APT-SNAP Platform for Rapid Identification ofNuclease-Resistant RNA Aptamers against p53 Missense Mutations Complete
1999 R43 PAR-98-066 CRONIN, MAUREEN T. PROTOGENE LABORATORIES, INC. DEVELOPMENT OF DNA MICROARRAY FABRICATION METHOD Complete
2002 R21 PAR-01-104 HEYDUK, TOMASZ SAINT LOUIS UNIVERSITY MOLECULAR BEACONS FOR PROTEIN DETECTION Complete
2005 R21 RFA-CA-05-002 POOLE, LESLIE B WAKE FOREST UNIVERSITY HEALTH SCIENCES PROFILING OF REDOX-SENSITIVE SIGNALING PROTEINS Complete
2008 R21 RFA-CA-07-033 WANG, TZA-HUEI JOHNS HOPKINS UNIVERSITY NANOBIOSENSING METHOD FOR POINT MUTATION DETECTION OF CANCER Complete
2011 R21 RFA-CA-10-001 GULLEY, MARGARET L UNIV OF NORTH CAROLINA CHAPEL HILL ENHANCED FORMALIN FIXATION TO IMPROVE TESTS ON SOLID TISSUES Complete
2015 R21 RFA-CA-14-003 IAFRATE, ANTHONY JOHN MASSACHUSETTS GENERAL HOSPITAL HIGHLY MULTIPLEXED FISH FOR IN SITU GENOMICS Complete
2018 R21 RFA-CA-17-010 BRENT, ROGER FRED HUTCHINSON CANCER RESEARCH CENTER Precision controllers of mammalian gene expression Complete
1999 R21 PAR-98-067 BENSIMON, AARON PASTEUR INSTITUTE DETECTION OF GENOMIC ALTERATIONS BY MOLECULAR COMBING Complete
2001 R33 PAR-99-100 WEISSMAN, SHERMAN MORTON YALE UNIVERSITY DISPLAY METHODS FOR SURVEYING MUTATIONS Complete
2003 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete
2007 R21 RFA-CA-07-003 BEEBE, DAVID J UNIVERSITY OF WISCONSIN-MADISON MICROFLUIDIC CHANNELS FOR HIGH DENSITY, HIGH PERFORMANCE CULTURE ASSAYS Complete
2010 R21 RFA-CA-09-004 HANSEN, KIRK C UNIVERSITY OF COLORADO DENVER METHODS FOR THE ANALYSIS OF TUMOR EXTRACELLULAR MATRIX Complete
2014 R21 RFA-CA-13-001 TEMPST, PAUL SLOAN-KETTERING INST CAN RESEARCH IMMOBILIZED PROTEASE ACTIVITY TESTS FOR DEVELOPING FUNCTIONAL CANCER BIOMARKERS. Complete
2017 R21 RFA-CA-16-001 DAVIS, RONALD WAYNE STANFORD UNIVERSITY Nanoneedle microrobots for single cancer cell manipulation and genome editing Complete
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Complete
2000 R43 PAR-99-101 RENARD, ANDRE INTERGEN COMPANY PYRENE-CONTAINING PROBES FOR MUTATION DETECTION Complete
2002 R43 PAR-01-105 MC GARRITY, GERARD J. INTRONN, INC. PRE-MRNA TRANS-SPLICING FOR MOLECULAR IMAGING OF CANCER Complete
2006 R33 RFA-CA-06-002 KNOWLES, DAVID W. UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB NOVEL IMAGE-BASED SCREENING OF MAMMARY TUMORS Complete
2009 R21 RFA-CA-08-006 MESSMER, DAVORKA UNIVERSITY OF CALIFORNIA SAN DIEGO REAL TIME QUANTITATIVE MULTIPLEX ANALYSIS OF CELL-CELL INTERACTIONS Complete
2013 R21 RFA-CA-12-002 ONG, SHAO-EN UNIVERSITY OF WASHINGTON KINASE PROFILING WITH QUANTITITATIVE CHEMOPROTEOMICS Complete
2016 R33 RFA-CA-15-003 NAGRATH, SUNITHA UNIVERSITY OF MICHIGAN HIGH THROUGHPUT GO CHIP ISOLATION OF LUNG CTCS FOR MOLECULAR DIAGNOSIS AND DRUG TESTING Complete
2019 R33 RFA-CA-18-005 LEI, YUGUO UNIVERSITY OF NEBRASKA LINCOLN A Single Conical Tube Device for Precision CAR-T Cells Manufacturing Complete
2000 R21 PAR-99-102 SMITH, RICHARD D BATTELLE PACIFIC NORTHWEST LABORATORIES HIGH THROUGHPUT FTICR FOR MOLECULAR ANALYSIS OF CANCER Complete
2002 R33 PAR-99-100 CONDEELIS, JOHN S YESHIVA UNIVERSITY NOVEL IMAGING METHODS FOR GENE DISCOVERY IN CANCER Complete
2005 R43 RFA-CA-05-006 KIM, RAYMOND GENEPRISM, INC. MULTIPLEXED PROTEIN BIOCHIP ASSAYS--SIGNAL AMPLIFICATION Complete

Pages